Financial Services
Live Price
Offline$76.06
+0.00% today
Window Change
+38.46%
Window
Nov 19, 2025 โ Jun 23, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 45 bars ยท Nov 19, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BB Biotech AG (BBAGF) is a Financial Services stock with a market cap of $2.49B. The stock last traded around $76.06 and up 38.5% across the available one-year price window (Nov 19, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of +425.9%, EPS growth of +665.2%, a dividend yield of 5.0%. What stands out right now is revenue +425.9%, EPS +665.2%, free cash flow +1.5% with operating margin 171.9% and ROIC -1.7%. The dividend matters to the case here, with a current yield around 5.0%. Stock Foundry combines BBAGF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+425.9% vs +3.4% peer median
Operating Margin
Above sector median
+171.9% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 23, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +425.9% and EPS at +665.2%, with operating margin around 171.9%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 5.0%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +12.8% over the next 5 trading days and finished higher after 1 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 23, 2026 | โ | +0.0% | +0.0% | +0.0% |
2026 Feb 19, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Jul 25, 2025 | โ | +0.1% | +38.5% | +38.5% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BBAGF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BBAGF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for BBAGF and SPY.
Company Overview
BB Biotech AG
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.